Abstract:Mitochondria, with their intricate networks of functions and information processing, are pivotal in both health regulation and disease progression. Particularly, mitochondrial dysfunctions are identified in many common pathologies, including cardiovascular diseases, neurodegeneration, metabolic syndrome, and cancer. However, the multifaceted nature and elusive phenotypic threshold of mitochondrial dysfunction complicate our understanding of their contributions to diseases. Nonetheless, these complexities do not prevent mitochondria from being among the most important therapeutic targets. In recent years, strategies targeting mitochondrial dysfunction have continuously emerged and transitioned to clinical trials. Advanced intervention such as using healthy mitochondria to replenish or replace damaged mitochondria, has shown promise in preclinical trials of various diseases. Mitochondrial components, including mtDNA, mitochondria-located microRNA, and associated proteins can be potential therapeutic agents to augment mitochondrial function in immunometabolic diseases and tissue injuries. Here, we review current knowledge of mitochondrial pathophysiology in concrete examples of common diseases. We also summarize current strategies to treat mitochondrial dysfunction from the perspective of dietary supplements and targeted therapies, as well as the clinical translational situation of related pharmacology agents. Finally, this review discusses the innovations and potential applications of mitochondrial transplantation as an advanced and promising treatment.

What problem does this paper attempt to address?

This paper aims to explore the mechanisms of mitochondrial dysfunction and its latest progress in treatment. Specifically, the paper focuses on the following aspects: 1. **Mechanisms of mitochondrial dysfunction**: The paper discusses in detail the role of mitochondria in various common diseases, including cardiovascular diseases, neurodegenerative diseases, metabolic syndrome, and cancer. The multifaceted nature of mitochondrial dysfunction and the elusiveness of the phenotypic threshold increase the complexity of understanding its contribution to diseases. 2. **Development of treatment strategies**: Despite these complexities, mitochondria remain one of the most important therapeutic targets. In recent years, treatment strategies for mitochondrial dysfunction have emerged continuously and have entered the clinical trial stage. These strategies include: - **Dietary supplements**: For example, combating nutritional deficiencies by supplementing specific nutrients. - **Drug interventions**: Such as using MitoQ to neutralize mitochondria - derived reactive oxygen species (ROS), coenzyme Q10 (CoQ10), N - acetylcysteine (NAC), etc. - **Gene therapy**: Such as gene replacement therapy and gene - editing techniques to deal with hereditary mitochondrial defects. - **Mitochondrial transplantation**: Using healthy mitochondria to supplement or replace damaged mitochondria, which has shown potential in pre - clinical trials of various diseases. 3. **Current status of clinical translation**: The paper also summarizes the clinical translation of relevant pharmacological drugs, emphasizing the challenges and prospects of these treatment methods in practical applications. 4. **Mitochondrial signal transduction**: Mitochondria not only play a crucial role in energy production and metabolic regulation but also play an important role in cell fate determination. The paper discusses how mitochondria affect cell function and integrity through pathways such as calcium ion homeostasis, AMPK and mTOR signaling pathways, and innate immune responses. In conclusion, this paper aims to provide a comprehensive perspective on the mechanisms of mitochondrial dysfunction and its treatment progress in common diseases, providing guidance for future clinical management and research.

Mitochondrial dysfunction: mechanisms and advances in therapy

Therapeutic and tampering approaches for mitochondrial associated diseases

Mitochondrial Dysfunction: A Promising Therapeutic Target for Liver Diseases

Mitochondrial Dysfunction in Cardiac Diseases and Therapeutic Strategies

Mitochondrial transplantation: A promising therapy for mitochondrial disorders

Targeting mitochondrial quality control: new therapeutic strategies for major diseases

Mitochondrial dysfunction and mitochondrial therapies in heart failure

Mitochondrial Dysfunction and Therapeutic Perspectives in Cardiovascular Diseases

Mitochondrial Transfer in Cardiovascular Disease: From Mechanisms to Therapeutic Implications

[Mitochondrial therapy: a new strategy for treating mitochondrion-associated diseases]

Mitochondrial dysfunction as a therapeutic strategy for neurodegenerative diseases: Current Insights and Future Directions

Mitochondrial transfer - a novel promising approach for the treatment of metabolic diseases

Targeted mitochondrial delivery: A therapeutic new era for disease treatment

Mitochondria as a therapeutic target for common pathologies

The role of mitochondrial dynamics in disease

Mitochondrial Transfer/transplantation: an Emerging Therapeutic Approach for Multiple Diseases

Mitochondrial transfer in the progression and treatment of cardiac disease

Mitochondria in health, disease, and aging

Assessment of mitochondrial dysfunction and implications in cardiovascular disorders

Mitochondrial Dysfunction in Chronic Respiratory Diseases: Implications for the Pathogenesis and Potential Therapeutics

Mitochondrial transplantation: opportunities and challenges in the treatment of obesity, diabetes, and nonalcoholic fatty liver disease